Requip (ropinirole) is a prescription medicine for the treatment of Parkinson’s disease and moderate–to-severe primary Restless Legs Syndrome 1.
Requip (ropinirole) is widely approved, including by the FDA in the USA, the EMA in the EU, and the MHRA in the UK.
